Invesaro

Companies SHPH 10-Q

SEC filing · 10-Q

Shuttle Pharmaceuticals Holdings, Inc.: Quarterly report

Shuttle Pharmaceuticals reported zero revenue, an ongoing net loss, and substantial doubt regarding its ability to continue as a going concern.

Filed September 24, 2026 · period ended June 30, 2026

Negative for the company

What the numbers say

Diluted EPS -$3.10 versus -$32.91; cash fell by $999.7K to $90.2K; diluted share count up 801% (dilution).

Compared with the same period a year earlier, from the figures Shuttle Pharmaceuticals Holdings, Inc. reported to the SEC.

What happened

  • The company generated no revenue and recorded a net loss of $3,145,539 for the three months ended June 30, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Shuttle Pharmaceuticals Holdings, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.